by CytokineSociety in President's Letter

Dear Colleagues, Greetings from the International Cytokine and Interferon Society! I hope you and your family are staying safe during these still challenging times. Thankfully 2020 is behind us now. We have lived through the COVID-19 pandemic, an event that will continue to impact our lives for some time and likely alter how we live in the future. Despite the obvious difficulties of this past year, I can’t help but marvel at the scientific advances [READ MORE]

In Memorium

  • Joseph Sonnabend, a physician, virologist, and multi-talented individual, who participated in pioneering studies on virus replication and on the mechanism of action of interferon died in London on January 24, 2021. He will, however, be best remembered for his activism and contributions to research during the early stages of the AIDS epidemic. His career in general was certainly anything but conventional. [READ MORE] Share this:Click to share on Twitter (Opens in new window)Click to share [READ MORE]

2020 Young Investigator & Abstract Awardees

2020 Milstein Young Investigator Award Winners:

Every year three-five awards are granted to individuals who have made notable contributions to either basic or clinical research. This award is provided by a generous gift of the Milstein Family and all ICIS members who will attend the upcoming annual conference and who have received a Ph.D or M.D. within the previous 10 years are eligible, but may be extended by 1 year due to parental leave. [READ MORE]

2020 Sidney & Joan Pestka Graduate & Post Graduate Award Winners

Autumn York, PhDHanna H. Gray Postdoctoral FellowHoward Hughes Medical InstituteLaboratory of Richard FlavellDepartment of ImmunobiologyYale UniversityNew Haven, United States Dr. Autumn York is an HHMI Hanna Gray Fellow in Dr. Richard Flavell’s lab in the Department of Immunobiology at Yale University.  Her postdoctoral research investigates how the immune system interacts [READ MORE]

Abstract Submission & Abstract Awards Deadline: 1 June 2021

  • Cytokines 2021 Hybrid Meeting
    A Hybrid Experience: In-person and Online Presentations & Sessions Our annual gatherings of investigators from academia, government, and industry offer exciting opportunities for you to discuss the latest breakthroughs in cytokine and interferons biology. Accommodating scientists from diverse biomedical backgrounds, the conference has an established tradition of showcasing major scientific discoveries affecting societal health and wellbeing. We very much look forward to continuing this strong tradition in Cardiff this coming October. The global pandemic continues to [READ MORE]


The ICIS-Pfizer Award for Excellence in Interferon and Cytokine Research (formerly the Seymour & Vivian Milstein Award from 1988 – 2020)

The ICIS-Pfizer Award for Excellence in Interferon and Cytokine Research (formerly the Seymour & Vivian Milstein Award from 1988 – 2020), represents the pinnacle of scientific achievement in interferon and cytokine research since 1988, two years after interferon was first approved for the treatment of hairy cell leukemia. Since that time, it has been widely recognized that interferons and the larger class of cytokines play critical roles in the development and progression of many major diseases including cancer, viral diseases such as hepatitis and influenza, and autoimmune disorders like multiple sclerosis and lupus. [READ MORE]

Pfizer Trainee Awards for Most Promising Research Presentations at the Cytokines Annual Meeting

All ICIS member trainees (students, postdocs and fellows) are invited to apply for a Pfizer Trainee Award at the time of abstract submission, before the June 1, 2021 deadline.

Up to four (4) trainees with the highest scoring abstracts as per the scientific review committee, will be awarded $1,250 each and will be invited to give an oral presentation at Cytokines 2021 Hybrid Meeting, recognized as a PfizerTrainee Presentation, in the most appropriate session based on topic. [READ MORE]

2021 Vilcek Foundation Prizewinners in Biomedical Science

The Vilcek Foundation Prizes in Biomedical Science celebrate the contributions of immigrant scientists to biomedical research and discovery in the United States
The Vilcek Foundation has announced the recipients of the 2021 Vilcek Foundation Prizes in Biomedical Science. Ruth Lehmann, director of the Whitehead Institute for Biomedical Research is the recipient of the 2021 Vilcek Prize in Biomedical Science. The 2021 Vilcek Prizes for Creative Promise in Biomedical Science are presented to Mohamed Abou Donia, Ibrahim Cissé, and Silvi Rouskin. [READ MORE]

New Member Mini-Bios

Maryam Mukhamedova, PhD

Maryam Mukhamedova, PhDPost-Doctoral FellowVaccine Research Center, NIAID, NIH, USAMaryam Mukhamedova is a post-doctoral fellow at the Vaccine Research Center, NIAID, NIH, USA in Dr. John Mascola’s Virology laboratory. She defended her thesis entitled “Genetic Characterization [READ MORE]

James Turkson, PhD (Chair of Cytokines 2022 in Hawaii)

James Turkson, PhD (Chair of Cytokines 2022 in Hawaii)Professor, Department of Medicine, Division of Medical OncologyAssociate Director of Strategic PartnershipsCedars-Sinai Medical Center, Los Angeles, CA USATurkson LabDr. James Turkson joined Cedars-Sinai Medical Center in Los [READ MORE]

Wei Chen, PhD

Wei Chen, PhDPostdoctoral FellowNIH/NCIRockville, MD USADr. Chen received his B.A and the veterinary medicine degree from Jilin University (JLU) in China. He trained in microbiology from the Institut Pasteur of Shanghai, Chinese Academy of Sciences [READ MORE]

Kristina Adams Waldorf, MD

Kristina Adams Waldorf, MDProfessor, Obstetrics & Gynecology and Global Health UW Medicine, Seattle, WA USADr. Kristina Adams Waldorf is a Professor in the Departments of Obstetrics & Gynecology and Global Health at the University of Washington [READ MORE]

De’Broski R. Herbert, PhD

De’Broski R. Herbert PhDAssociate Professor of ImmunologyUniversity of Pennsylvania, PennVetPhiladelphia, PA USAThe Herbert laboratory explores the cellular and molecular regulatory networks controlling the inflammation that drives host protective immunity and tissue repair in humans and [READ MORE]

Rebecca Porritt, PhD

Rebecca Porritt, PhDResearch Scientist I, Department of Pediatrics and Biomedical SciencesAssistant Professor of Pediatrics, UCLA School of MedicineCedars-Sinai Medical Center, Los Angeles, CA, USADr. Porritt is a faculty research scientist in the Departments of Pediatrics [READ MORE]

Moshe Arditi, M.D.

Moshe Arditi, M.D.Executive Vice-Chair, Department of Pediatrics for ResearchProfessor of Pediatrics, Cedars Sinai Medical Center and UCLA School of MedicineDirector, Division of Pediatric Infectious Diseases and Immunology,Director, Infectious and Immunologic Diseases Research Center (IIDRC), Department [READ MORE]

Clinical Trials

Clinical Trials

By Marta Catalfamo Study of Intratumorally Administered Stimulator of Interferon Genes (STING) Agonist E7766 in Participants With Advanced Solid Tumors or Lymphomas – INSTAL-101 Principal Investigators: Beth Israel Deaconess Medical Center. Boston, Massachusetts, United States, [READ MORE]

Special Article of Interest

Industry News

  • By Supreet Agarwal Cytokines represent the major class of all the soluble ligands targeted by FDA-approved drugs Major cytokines’ (interferons, interleukins and chemokines) targeted therapiesFigures adapted from:Attwood, M.M., Jonsson, J., Rask-Andersen, M. et al. Soluble ligands as drug targets. Nat Rev Drug Discov 19, 695–710 (2020). https://doi.org/10.1038/s41573-020-0078-4 Cytokines based therapies approved in 2020Two new treatments for patients with a condition called, deficiency of interleukin-1 receptor antagonist, a very rare genetic inflammatory condition resembling an infection throughout the body or a bone infection [READ MORE]

Other Meetings of Interest

Signals+ PDF

  • Signals+ Newsletter in PDF format for viewing, downloading and/or printing. Share this:Click to share on Twitter (Opens in new window)Click to share on Facebook (Opens in new window)

Stay connected & please share